Novartis launches new $11 billion share buyback

ZURICH (Reuters) -Novartis has formally launched its new share buyback programme where it could spend up to 10 billion Swiss francs ($10.90 billion) repurchasing its shares over the next three years.

苏黎世（路透社）——诺华公司已正式启动其新的股票回购计划，该计划可能在未来三年内花费高达 100 亿瑞士法郎（109 亿美元）回购其股票。

The Swiss company said it will buy a maximum of 10% of its own stock over the period from its last Annual General Meeting, which took place on March 7, up to the AGM in 2026.

这家瑞士公司表示，从 3 月 7 日举行的上届年度股东大会到 2026 年年度股东大会期间，它将购买最多 10% 的自有股票。

Capital reductions of the registered shares repurchased under the scheme will be proposed at future AGMs, Novartis said.

诺华表示，将在未来的年度股东大会上提议根据该计划回购的注册股份减少资本。

Shareholders approved rolling over the remaining authorisation of 6.5 billion francs for buybacks at their AGM last week. The amount was topped up to 10 billion francs in total.

上周，股东们在年度股东大会上批准将剩余的 65 亿瑞士法郎授权用于回购。总额达100亿法郎。

Novartis has just completed the repurchase of 213 million of its shares in the period between March 2020 and March 10 2023.

诺华刚刚在2020年3月至2023年3月10日期间完成了2.13亿股股份的回购。

This amounted to 8.9% of its shares, which have either been cancelled or will be proposed for cancellation at AGMs.

这相当于其股份的 8.9%，这些股份已被注销或将在年度股东大会上被提议注销。

($1 = 0.9162 Swiss francs)

($1 = 0.9162 瑞士法郎)

($1 = 0.9171 Swiss francs)

($1 = 0.9171 瑞士法郎)

(Reporting by John RevillEditing by Paul Carrel)

（约翰·雷维尔报道，保罗·卡雷尔编辑）